Enfusion Newsroom

William Blair Maintains Enfusion(ENFN.US) With Hold Rating

Moomoo NewsJan 18 11:32 ET

William Blair Maintains Enfusion(ENFN.US) With Hold Rating

Moomoo NewsJan 14 08:34 ET

Morgan Stanley Downgrades Enfusion(ENFN.US) to Hold Rating, Raises Target Price to $11.25

Moomoo NewsJan 14 05:38 ET

Analysts Have Conflicting Sentiments on These Technology Companies: Clearwater Analytics Holdings (CWAN) and Enfusion (ENFN)

TipRanksJan 14 05:15 ET

Enfusion Downgraded to Equal Weight From Overweight at Morgan Stanley

TipRanksJan 14 05:06 ET

Enfusion Cut to Market Perform From Outperform by William Blair

Dow JonesJan 13 14:34 ET

Enfusion Analyst Ratings

BenzingaJan 13 14:23 ET

William Blair Downgrades Enfusion(ENFN.US) to Hold Rating

Moomoo NewsJan 13 12:31 ET

Enfusion (ENFN) Was Downgraded to a Hold Rating at William Blair

TipRanksJan 13 12:07 ET

Stifel Downgrades Enfusion(ENFN.US) to Hold Rating, Cuts Target Price to $11.25

Moomoo NewsJan 13 10:31 ET

Stifel Downgrades Enfusion to Hold From Buy, $11.25 Price Target

MT NewswiresJan 13 10:15 ET

Piper Sandler Maintains Neutral on Enfusion, Raises Price Target to $11.5

BenzingaDec 23, 2024 07:29 ET

Piper Sandler Maintains Enfusion(ENFN.US) With Hold Rating, Raises Target Price to $11.5

Moomoo NewsDec 23, 2024 05:31 ET

Enfusion (ENFN) Receives a Hold From Piper Sandler

TipRanksDec 23, 2024 04:58 ET

Stifel Maintains Enfusion(ENFN.US) With Buy Rating, Raises Target Price to $13

Moomoo NewsDec 18, 2024 15:32 ET

Enfusion Is Maintained at Buy by Stifel

Dow JonesDec 18, 2024 12:23 ET

Enfusion Analyst Ratings

BenzingaDec 18, 2024 12:13 ET

Morgan Stanley Maintains Enfusion(ENFN.US) With Buy Rating, Maintains Target Price $11

Moomoo NewsNov 5, 2024 06:31 ET

Stifel Maintains Enfusion(ENFN.US) With Buy Rating, Raises Target Price to $11

Moomoo NewsNov 4, 2024 16:31 ET

Enfusion: Strong Client Acquisitions and Strategic Positioning Drive Buy Rating

TipRanksNov 4, 2024 15:38 ET